Free tool
Oncology stocks
We cover 3 companies grouped under the Oncology theme. The median market value in the group is $244.61M. Across the group, the median move over the past trading day is +3.36%. Price change over the past year runs from −1.5% to +3.2% across the middle 80 percent of the group, with a median of +2.4%.
Other lists in this group
SaaSAI applicationsCybersecuritySemiconductor designSemiconductor equipmentFintech softwarePayment processingEcommerce marketplacesStreaming mediaGaming softwareOncologyRare diseaseMedical devicesCell therapyDiagnosticsRegional banksAsset managementGold miningCryptocurrency and digital assetsSpecialty chemicalsAll stocks
Table
3 of 319 companies match these filters.Clear filters
| Ticker | Company | Market cap (USD) | Size | 1Y return | Next report |
|---|---|---|---|---|---|
| PRTC.L | PureTech Health plc | $420.70M | Small cap | +2.43% | Sep 3, 2026 |
| IPH.PA | Innate Pharma S.A. | $244.61M | Small cap | +3.36% | Sep 17, 2026 |
| IDD.DE | Innate Pharma S.A. | $231.60M | Small cap | −2.52% | Sep 17, 2026 |
Covers ~22,000 companies across the US, Europe and Asia-Pacific (ex mainland China, Hong Kong and India), refreshed nightly. Every listed stock opens as a full analysis for $9.90.